- Sputnik International
Russia
The latest news and stories from Russia. Stay tuned for updates and breaking news on defense, politics, economy and more.

Russia's RDIF, ChemRar Start Exporting Avifavir Medication Against COVID-19

© REUTERS / Andrey Rudakov/Russian Direct Investment Fund (RDIF)An employee demonstrates packages with new antiviral drug Avifavir, produced by manufacturer ChemRar and approved by Russian authorities to treat patients suffering from the coronavirus disease (COVID-19), at a storage in Moscow, Russia, in this handout photo released June 10, 2020
An employee demonstrates packages with new antiviral drug Avifavir, produced by manufacturer ChemRar and approved by Russian authorities to treat patients suffering from the coronavirus disease (COVID-19), at a storage in Moscow, Russia, in this handout photo released June 10, 2020 - Sputnik International
Subscribe
MOSCOW (Sputnik) - The Russian Direct Investment Fund (RDIF) and the pharmaceutical group ChemRar have started exporting the drug Avifavir against COVID-19, Belarus has already received it, and deliveries to Kazakhstan are expected to start soon, RDIF said on Thursday.

"In June, the medication was delivered to 35 regions across Russia and to the Republic of Belarus. Avifavir will soon be delivered to the Republic of Kazakhstan, a relevant agreement has been reached. Over 100,000 more courses will be produced within a month", RDIF said in a statement.

According to Russia's sovereign wealth fund, talks are underway regarding Avifavir deliveries to Latin America, with a range of Commonwealth of Independent States nations and Middle Eastern countries also expressing interest.

In June, RDIF and ChemRar produced 100,000 courses of the medication, smashing the target of 60,000, RDIF said.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала